Forest Investigative Site 1802 — Charleston, South Carolina

Forest Investigative Site 1802 is a clinical research site located in Charleston, South Carolina, United States 29412.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1802 has participated in 2 clinical trials.

Therapeutic areas: Chronic Obstructive Pulmonary Disease.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1802?

Forest Investigative Site 1802 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1802 conducted?

Forest Investigative Site 1802 has 2 clinical trials on record. Their work covers Chronic Obstructive Pulmonary Disease.

Is Forest Investigative Site 1802 accredited by Crixeo Clinical Trials?

Forest Investigative Site 1802 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1802?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.